• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - depuis
Tag:

depuis

Health

Belgium: New Rules for Sick Leave & Return to Work in 2026

by Chief Editor January 8, 2026
written by Chief Editor

Belgium’s Workforce Revolution: Navigating New Rules for Employers and Employees

Belgium is undergoing a significant shift in its approach to employment, particularly concerning long-term illness and return-to-work strategies. As of January 1, 2026, a series of new regulations are in effect, aiming to boost the national employment rate to 80%. These changes impact businesses, workers, medical professionals, and mutual insurance funds, demanding adaptation and a proactive approach.

Shorter Absence Tolerances Without Medical Certificates

One of the most immediate changes concerns short-term absences. For companies with over 50 employees, the allowance for uncertified absences has been reduced from three days to two per year. This aims to discourage casual absenteeism and encourage prompt medical attention when needed. Smaller businesses remain unaffected, maintaining the three-day allowance. This shift reflects a broader trend towards stricter attendance policies across Europe, driven by concerns about productivity and cost.

Pro Tip: Employers should clearly communicate this change to their staff and update internal policies accordingly. A well-defined absence management system is crucial.

Accelerated Procedures for Medical Incapacity

The timeline for initiating a dismissal procedure due to long-term medical incapacity has been shortened. Previously, a nine-month period of consecutive incapacity was required. Now, that period has been reduced to six months. This acceleration aims to provide clarity and reduce uncertainty for both employers and employees facing long-term health challenges. A recent study by the European Agency for Safety and Health at Work highlights the increasing prevalence of work-related stress and mental health issues, making these changes particularly relevant.

Extended “Rechute” (Relapse) Periods for Benefit Eligibility

A significant change impacts workers returning from sick leave. The “rechute” period – the time frame within which a relapse results in loss of continued wage guarantee – has been extended from 14 days to eight weeks. This provides a greater buffer for employees re-integrating into the workplace, acknowledging the potential for setbacks during the recovery process. This aligns with best practices in occupational health, emphasizing a gradual and supported return to work.

Did you know? The extended rechute period doesn’t apply retroactively. It only affects incapacities beginning after January 1, 2026.

Shifting Financial Responsibility for Part-Time Medical Return

The financial responsibility for workers returning part-time due to medical reasons has also shifted. Previously, the mutual insurance fund covered benefits for up to 20 weeks after the return, with the employer taking over afterward. Now, the mutual insurance fund will continue coverage beyond the 20-week mark, provided the incapacity begins after January 1, 2026. This simplifies the process and ensures continuous support for employees during their rehabilitation.

Mandatory Contact and the Importance of Reintegration

Employers are now legally obligated to maintain regular contact with employees on sick leave. This isn’t just a matter of compliance; it’s a crucial element of successful reintegration. Companies must integrate a clear procedure for contact into their work regulations, outlining who will be responsible and how often communication will occur. This proactive approach fosters a supportive environment and demonstrates a commitment to employee well-being.

New Solidarity Contribution for Employers

A new solidarity contribution replaces the previous “responsibilization” contribution. Companies with 50 or more employees will now pay 30% of the incapacity benefits paid by the mutual insurance fund during the first two months following the wage guarantee period. This contribution, calculated by the ONSS (National Social Security Office), aims to incentivize employers to prioritize preventative measures and support employee health.

The Rise of Electronic Medical Certificates and Streamlined Processes

Belgium is moving towards the widespread adoption of electronic medical certificates. The initial phase involves integration between doctors and mutual insurance funds, with plans to eventually include employers. This digitalization promises to streamline the process, reduce administrative burdens, and improve data accuracy. Similar initiatives in countries like the Netherlands have demonstrated significant efficiency gains.

Future Trends: A Proactive and Preventative Approach

Personalized Return-to-Work Plans

We can expect to see a greater emphasis on personalized return-to-work plans tailored to the individual’s specific needs and capabilities. This will involve collaboration between employers, medical professionals, and the employee to create a sustainable and effective reintegration strategy.

Investment in Workplace Wellness Programs

Companies will increasingly invest in workplace wellness programs focused on preventative health, stress management, and mental well-being. These programs will not only improve employee health but also reduce absenteeism and boost productivity. Data from the World Health Organization shows a clear correlation between workplace wellness initiatives and reduced healthcare costs.

The Role of Technology in Monitoring and Support

Technology will play a growing role in monitoring employee health and providing support. Wearable devices, telehealth platforms, and AI-powered tools will enable early detection of health issues and facilitate remote monitoring and coaching.

Focus on “Presenteeism” – Addressing Hidden Costs

While absenteeism is a visible concern, “presenteeism” – being at work while sick or unwell – is a growing issue. Future policies will likely address presenteeism by promoting a culture of health and encouraging employees to take time off when needed.

Frequently Asked Questions (FAQ)

  • Q: What if my company has fewer than 50 employees?
    A: The reduction in uncertified absence allowance does not apply to companies with fewer than 50 employees.
  • Q: Does the extended rechute period apply to existing sick leave cases?
    A: No, it only applies to incapacities beginning after January 1, 2026.
  • Q: What is the solidarity contribution used for?
    A: It helps fund the incapacity benefits paid by the mutual insurance fund.
  • Q: Where can I find more information about these changes?
    A: Consult the UCM (Union des Classes Moyennes) website or your legal counsel.

These changes represent a significant step towards a more proactive and preventative approach to workforce health in Belgium. Adapting to these new regulations will require careful planning and a commitment to employee well-being. Staying informed and seeking expert advice will be crucial for navigating this evolving landscape.

Explore further: Understanding Belgian Labor Law | Building a Thriving Workplace Wellness Program

January 8, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

La survie à 3 ans a doublé depuis 2000

by Chief Editor July 8, 2025
written by Chief Editor

Lung Cancer Survival Rates: A Glimmer of Hope and Future Trends

The latest findings from the KBP-2020-CPHG study, published in The New England Journal of Medicine Evidence, offer encouraging insights into the evolving landscape of lung cancer treatment and survival. This article delves into the advancements, key factors influencing outcomes, and potential future trends in the fight against this formidable disease.

Dramatic Improvements in Survival

One of the most striking findings is the significant increase in overall survival rates. The three-year survival rate for lung cancer patients has jumped from 16.3% in 2000 to 38.6% in 2020. This means more people are living longer after their diagnosis. The median overall survival has also more than doubled, from 8.5 months in 2000 to 20.7 months in 2020. This is a testament to advancements in early detection, treatment strategies, and supportive care.

Did you know? Lung cancer is the leading cause of cancer deaths worldwide, but these survival improvements represent significant progress.

The Rise of Adenocarcinoma and Cancer Subtypes

The study also highlights a shift in the types of lung cancer being diagnosed. Adenocarcinoma, a specific type of non-small cell lung cancer (NSCLC), now accounts for 56.1% of lung cancers, up from less than a third in 2000. Understanding these different subtypes is crucial because it dictates treatment approaches. NSCLC is the most common form, encompassing adenocarcinoma, squamous cell carcinoma, and large-cell carcinoma. Small cell lung cancer (SCLC) is less common but often more aggressive.

Pro Tip: If you or a loved one has been diagnosed with lung cancer, insist on comprehensive testing to determine the specific subtype. This is vital for personalized treatment plans.

Gender, Stage, and Their Impact

The study underscores the importance of factors like gender and the stage of the cancer at diagnosis. In 2020, 45.1% of women with adenocarcinoma were alive after three years, compared to 34.2% of men. Early-stage detection is critical; patients with stage I localized disease had an 84% survival rate, while those with metastatic disease at diagnosis had a 21.3% survival rate. This emphasizes the need for early screening and prompt intervention. Learn more about the [importance of early detection](insert internal link to your early detection article).

Revolutionizing Treatment: Targeted Therapies and Immunotherapy

Several advancements have propelled improvements in patient outcomes. These include enhanced imaging techniques, the advent of minimally invasive surgery (including robotic surgery), and more precise histological classifications, particularly through immunohistochemistry. This technique helps identify specific proteins in tumor tissue to pinpoint cancer subtypes and guide treatment choices. Furthermore, molecular biology platforms have made it possible to identify mutations specific to each tumor (EGFR, ALK, ROS1).

The introduction of targeted therapies for patients with these mutations has significantly improved survival. In 2020, patients with these alterations who were treated with targeted therapies had a 36% three-year overall survival rate, compared to 18.5% without these therapies. Immunotherapy has also shown remarkable promise.

Immunotherapy’s Impact on Metastatic Disease

For patients without the specific molecular alterations targeted by precision medicine, immunotherapy has emerged as a game-changer. For patients with metastatic disease who received first-line immunotherapy, the three-year overall survival rate was 36.2% compared to 14.3% without it. The median survival rate also soared from 4.2 to 21 months. Explore the [different types of immunotherapy](insert internal link to your immunotherapy article).

Future Trends and Potential Advancements

The horizon for lung cancer treatment is filled with exciting possibilities. Several areas hold promise for further improvements in survival rates:

  • Personalized Medicine: Further development of targeted therapies based on individual genetic profiles.
  • Early Detection Techniques: Improved screening methods, including liquid biopsies that can detect cancer biomarkers in blood.
  • Combination Therapies: Combining immunotherapy with other treatments, such as chemotherapy and targeted therapies, to enhance effectiveness.
  • Artificial Intelligence (AI): AI-powered tools for more accurate diagnosis and personalized treatment planning.

As these trends evolve, collaboration between researchers, healthcare providers, and patient advocacy groups will be crucial for accelerating progress. Read more about [ongoing research in lung cancer treatment](insert external link to a reputable research institution).

Frequently Asked Questions

What is the most common type of lung cancer?

Non-small cell lung cancer (NSCLC) is the most prevalent, accounting for over 80% of cases. Adenocarcinoma is the most common subtype.

How is lung cancer diagnosed?

Diagnosis typically involves imaging tests (X-rays, CT scans, PET scans), biopsies to examine tissue samples, and blood tests.

What are the primary treatment options for lung cancer?

Treatment options include surgery, chemotherapy, radiation therapy, targeted therapies, and immunotherapy, often used in combination.

What lifestyle changes can reduce the risk of lung cancer?

The most significant risk factor is smoking. Quitting smoking, avoiding secondhand smoke, and adopting a healthy lifestyle, including a balanced diet and regular exercise, can significantly reduce your risk.

Source: Debieuvre D, Falchero L, Molinier O, et al. Survival of Patients with Lung Adenocarcinoma Diagnosed in 2000, 2010, and 2020. NEJM Evid. 2025 Jul;4(7):EVIDoa2400443. doi: 10.1056/EVIDoa2400443. Epub 2025 Jun 24. PMID: 40552964 ; site de l’Institut Curie Cancer du poumon (viewed July 7, 2025).

What are your thoughts on these findings? Share your experiences and questions in the comments below!

July 8, 2025 0 comments
0 FacebookTwitterPinterestEmail

Recent Posts

  • Zbigniew Ziobro: Ex-Lengthy Minister Finds Refuge in US

    May 10, 2026
  • Viktor Orbán Warns New Hungarian PM Against Sacrificing Sovereignty for EU Funds

    May 10, 2026
  • Vrem Guvernarea, Nu Oscioare Aruncate

    May 10, 2026
  • Robert Lewandowski Reaches 33 Career Trophies After La Liga Triumph

    May 10, 2026
  • vivo Launches V70 and Y31 5G Series in Tunisia: Prices and Specs

    May 10, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: o f f i c e @byohosting.com


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World